New Pharmacological Treatments for Pathologies in the Field of Women's Health, except Oncology.

Exeltis is a pharmaceutical company that arose as a result of the natural evolution and growth of the Insud Pharma Group, one of the leading manufacturers of active ingredients as well as drug developers for the global pharmaceutical industry. It is a transnational company based in Madrid, spanning five continents.

Exeltis develops innovative products in various therapeutic areas and is currently focused on expanding its product portfolio in the field of Women's Health.

Exeltis accompanies women at each and every stage of their lives (contraception, pregnancy, fertility and menopause) and offers a range of gynaecological products adapted to their needs and requirements in terms of reproductive health and associated pathologies and aimed at improving their health and quality of life.

In this context, the specific objectives of this Women's Health Challenge (with the exception of oncology) are:

- Research and development of new drugs for application in gynaecology and obstetrics (special interest in non-hormonal treatments).
- Research and development of food supplements and/or probiotics with beneficial action in conditions or pathologies associated with Women's Health.

‍

Exeltis is open to different collaboration formulas ranging from direct investment in the programme, co-development projects or patent licensing.

POSSIBLE APPLICATIONS
- New therapies in Gynaecology and Obstetrics.

- New food supplements and probioticS.

- New Pharmacological Treatments that focus on the symptoms of menopause